Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
J., Raymond, G
Acute in vivo administration and ex vivo analysis was performed to elucidate the mechanisms of ASHMI (4.5 mg/mouse twice daily) inhibition of airway hyperreactivity and tracheal ring constriction
patent system
Stay compliant with the latest regulatory benchmarks: Read the FDA Peptide Sameness Study Requirements Major Impurity Classes Detected Using LC-MS Truncated peptides Sequence variants D-amino acid isomers Lipid chain variants Oxidation products Deamidated peptides High-resolution LC-MS workflows enable precise mass measurement and fragmentation-based identification
US$ 26.87
US$ 20.72
US$ 27.08
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
